ATE444744T1 - Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes - Google Patents
Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetesInfo
- Publication number
- ATE444744T1 ATE444744T1 AT06749448T AT06749448T ATE444744T1 AT E444744 T1 ATE444744 T1 AT E444744T1 AT 06749448 T AT06749448 T AT 06749448T AT 06749448 T AT06749448 T AT 06749448T AT E444744 T1 ATE444744 T1 AT E444744T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- blood sugar
- reducing blood
- treating diabetes
- sugar levels
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 239000008280 blood Substances 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 title abstract 2
- 230000000295 complement effect Effects 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N (+)-Erythro-hydroxycitric acid Natural products OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 abstract 2
- 240000005373 Panax quinquefolius Species 0.000 abstract 2
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 2
- 229940046374 chromium picolinate Drugs 0.000 abstract 2
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 abstract 2
- 235000020230 cinnamon extract Nutrition 0.000 abstract 2
- 229940025902 konjac mannan Drugs 0.000 abstract 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 abstract 2
- 239000011777 magnesium Substances 0.000 abstract 2
- 159000000003 magnesium salts Chemical class 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- ZMJBYMUCKBYSCP-AWFVSMACSA-N (1s,2r)-1,2-dihydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)[C@@H](O)[C@@](O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-AWFVSMACSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 235000019136 lipoic acid Nutrition 0.000 abstract 1
- 229960002663 thioctic acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66968205P | 2005-04-07 | 2005-04-07 | |
| PCT/US2006/012903 WO2006110491A2 (en) | 2005-04-07 | 2006-04-07 | Complementary compositions to reduce blood glucose levels and treat diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE444744T1 true ATE444744T1 (de) | 2009-10-15 |
Family
ID=36999982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06749448T ATE444744T1 (de) | 2005-04-07 | 2006-04-07 | Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7687082B2 (de) |
| EP (1) | EP1874285B1 (de) |
| AT (1) | ATE444744T1 (de) |
| AU (1) | AU2006235123A1 (de) |
| DE (1) | DE602006009641D1 (de) |
| WO (1) | WO2006110491A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007217500A1 (en) * | 2006-02-21 | 2007-08-30 | Astrum Therapeutics Pty. Ltd. | Compositions to reduce blood glucose levels and treat diabetes |
| US8652550B2 (en) | 2008-01-16 | 2014-02-18 | Hydro One, Llc | Health beverages comprising cinnamon extract and methods of making and using the same |
| CA2642184A1 (en) * | 2008-10-28 | 2010-04-28 | Goliath Oil And Gas Corporation | Composition containing ginseng and cinnamon |
| US9918489B2 (en) * | 2008-12-17 | 2018-03-20 | Mark Gorris | Food-based supplement delivery system |
| US20100178413A1 (en) * | 2008-12-17 | 2010-07-15 | Mark Gorris | Food-based Supplement Delivery System |
| ES2395529B1 (es) | 2011-06-08 | 2014-04-11 | Pri, S.A. | Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2. |
| CN102526198A (zh) * | 2012-03-14 | 2012-07-04 | 南昌大学 | 一种以肉桂和铬为添加剂的药品及保健品的制备方法 |
| CN103436582B (zh) * | 2013-07-10 | 2015-12-23 | 马杰坤 | 一种魔芋多肽提取物、制备方法及其用途 |
| GB201319525D0 (en) * | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition |
| IT202300000027A1 (it) * | 2023-01-03 | 2024-07-03 | Associazione Filantropica Cashaid | Composizione per trattare il diabete normalizzando la glicemia |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08127538A (ja) * | 1994-10-31 | 1996-05-21 | Masakiyo Takahashi | 糖尿病治療薬 |
| US5962030A (en) | 1997-03-07 | 1999-10-05 | Akesis Pharmaceuticals, Inc. | Dietary supplement and method of treatment for diabetic control |
| US6376549B1 (en) * | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
| AU4031500A (en) * | 1999-03-26 | 2000-10-16 | Akesis Pharmaceuticals, Inc. | Edible solids for treatment of glucose metabolism disorders |
| US6562836B1 (en) | 1999-05-24 | 2003-05-13 | Queen's University Of Kingston | Methods and compounds for inhibiting amyloid deposits |
| US6207714B1 (en) * | 1999-09-14 | 2001-03-27 | Dallas L. Clouatre | Methods and pharmaceutical preparations for improving glucose metabolism with (−)-hydroxycitric acid |
| CA2310513A1 (en) * | 2000-05-31 | 2001-11-30 | Vladimir Vuksan | Compositions and methods for reducing blood glucose |
| US7326404B2 (en) * | 2000-05-31 | 2008-02-05 | Vuksan Holdings Inc. | Konjac-mannan and ginseng compositions and methods and uses thereof |
| WO2002036202A2 (en) * | 2000-11-02 | 2002-05-10 | Nutrition 21, Inc. | Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid |
| TWI329516B (en) * | 2000-12-12 | 2010-09-01 | Kaneka Corp | Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity |
| US20020147153A1 (en) * | 2001-02-14 | 2002-10-10 | Functional Foods, Inc. | Nutritional supplement to alleviate symptoms associated with reduced levels of serotonin |
| US6849613B2 (en) * | 2001-08-29 | 2005-02-01 | Kedar N. Prasad | Multiple antioxidant micronutrients |
| AU2003225442B2 (en) | 2002-03-08 | 2010-02-04 | Philera New Zealand Limited | Preventing and/or treating cardiovascular disease and/or associated heart failure |
| US6787163B2 (en) | 2003-01-21 | 2004-09-07 | Dennis H. Harris | Therapeutic treatment for blood sugar regulation |
| CN1302712C (zh) * | 2005-11-08 | 2007-03-07 | 南京中脉科技发展有限公司 | 一种减肥饼干及其制备方法 |
-
2006
- 2006-04-07 AT AT06749448T patent/ATE444744T1/de not_active IP Right Cessation
- 2006-04-07 EP EP06749448A patent/EP1874285B1/de not_active Not-in-force
- 2006-04-07 AU AU2006235123A patent/AU2006235123A1/en not_active Abandoned
- 2006-04-07 US US11/400,777 patent/US7687082B2/en not_active Expired - Fee Related
- 2006-04-07 WO PCT/US2006/012903 patent/WO2006110491A2/en not_active Ceased
- 2006-04-07 DE DE602006009641T patent/DE602006009641D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20060251736A1 (en) | 2006-11-09 |
| US7687082B2 (en) | 2010-03-30 |
| DE602006009641D1 (de) | 2009-11-19 |
| EP1874285A2 (de) | 2008-01-09 |
| WO2006110491A2 (en) | 2006-10-19 |
| EP1874285B1 (de) | 2009-10-07 |
| WO2006110491A3 (en) | 2007-04-05 |
| AU2006235123A1 (en) | 2006-10-19 |
| WO2006110491B1 (en) | 2007-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602007006641D1 (de) | Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes | |
| EA201300522A1 (ru) | Фармацевтические комбинации для лечения метаболических нарушений | |
| EA200900940A1 (ru) | Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное | |
| ATE539748T1 (de) | Glucokinaseaktivatoren | |
| EA201000515A1 (ru) | Активаторы глюкокиназы | |
| WO2006105440A3 (en) | Nicotinamide riboside and analogues thereof | |
| WO2008108957A3 (en) | Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain | |
| WO2007002572A3 (en) | Nattokinase for reducing whole blood viscosity | |
| NO20064584L (no) | Tetrahydropyridoindolderivater | |
| MY152037A (en) | Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative | |
| WO2005023083A3 (en) | Compositions and methods for the treatment of severe acute respiratory syndrome (sars) | |
| EA200501936A1 (ru) | Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv | |
| SG155188A1 (en) | Pyrrole derivatives as pharmaceutical agents | |
| TW200738246A (en) | Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives | |
| MX2010001560A (es) | Composicion farmaceutica que comprende un inhibidor de sglt2 en combinacion con un inhibidor de dpp-iv. | |
| EA200900626A1 (ru) | Комбинированное лечение ингибиторами sglt-2 (натрийзависимый сопереносчик глюкозы 2) и содержащими их фармацевтическими композициями | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| WO2008078176A9 (en) | Methods, compounds, and compositions for treating metabolic disorders and diabetes | |
| ATE444744T1 (de) | Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes | |
| UA106209C2 (en) | Choline cocrystal of 5-[(1z,2e)-2-methyl-3-phenylpropenylidene]-4-oxo-2-thioxo-3-thiazolidine acetic acid | |
| WO2007002836A3 (en) | Methods and compositions for the prevention and treatment of kidney disease | |
| TW200616985A (en) | Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use | |
| WO2007023154A3 (de) | EISEN(III)-KOMPLEXVERBINDtMGEN ZUR BEHANDLUNG VON EISENMANGEL-ZUSTÄNDEN BEI PATIENTEN MIT CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNG | |
| EP1968561B8 (de) | Behandlung von diabetischer nephropathie | |
| WO2006133194A3 (en) | Methods for treating viral infection with oral or injectible drug solution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |